We are live on ! Find out more
TA

Tamarack Advisers Portfolio holdings

AUM $2.12M
1-Year Est. Return 58.09%
This Fund
S&P 500
This Quarter Est. Return
+12.23%
1 Year Est. Return
-58.09%
3 Year Est. Return
-46.51%
5 Year Est. Return
+44.44%
10 Year Est. Return
–
AUM
$299M
AUM Growth
+$88.5M
Cap. Flow
+$67.2M
Cap. Flow %
22.49%
Top 10 Hldgs %
67.92%
Holding
32
New
5
Increased
19
Reduced
3
Closed
4

Top Buys

Rank Stock Value
1
OPTN
OptiNose
OPTN
+$12.2M
2
MDT icon
Medtronic
MDT
+$11.2M
3
LH icon
Labcorp
LH
+$9.84M
4
RIGL icon
Rigel Pharmaceuticals
RIGL
+$9.34M
5
LNTH icon
Lantheus
LNTH
+$8.76M

Top Sells

Rank Stock Value
1
QDEL icon
QuidelOrtho
QDEL
+$8.55M
2
ALKS icon
Alkermes
ALKS
+$6.38M
3
STE icon
Steris
STE
+$4.2M
4
CERN
Cerner Corp
CERN
+$2.61M
5
VSI
Vitamin Shoppe Inc.
VSI
+$1.06M

Sector Composition

Rank Sector Weight
1 Healthcare 89.45%
2 Industrials 5.46%
3 Consumer Discretionary 4.47%
4 Miscellaneous 0.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
26
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$815B
$936K 0.31%
+6,000
New +$1.62M
PDCO
27
PUT
DELISTED
Patterson Companies, Inc.
PDCO
$469K 0.16%
+1,630
New +$36.7K
HSIC icon
28
PUT
Henry Schein
HSIC
$10B
$425K 0.14%
+1,275
New +$71.9K
ALKS icon
29
Alkermes
ALKS
$7.73B
– –
-110,000
Closed -$6.38M
QDEL icon
30
QuidelOrtho
QDEL
$958M
– –
-165,000
Closed -$8.55M
STE icon
31
Steris
STE
$21.9B
– –
-45,000
Closed -$4.2M
CERN
32
DELISTED
Cerner Corp
CERN
– –
-45,000
Closed -$2.61M
1
2

Similar funds

SCM
SevenOneSeven Capital Management Lancaster, Pennsylvania $2.17M AUM 8.67% 1-Year Est. Return
LBC
Lawrence B. Cohen $2.06M AUM 34.47% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
LCMP
Linse Capital Management PR San Juan, Puerto Rico $2.31M AUM
GIP
General Industrial Partners London, United Kingdom $2.57M AUM
STC
Sarah T. Connolly $1.11M AUM 24.13% 1-Year Est. Return
GC
Gilfoyle & Co San Francisco, California $671K AUM
DU
Delphia (USA) Toronto, Ontario, Canada $445K AUM 28.82% 1-Year Est. Return

Tamarack Advisers's Q2 2018 Portfolio in Review

As of Q2 2018, Tamarack Advisers held 32 positions worth $299M, up 42% from $210M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Tamarack Advisers deployed $67.2M of net new capital in Q2 2018, opening 5 new positions and adding to 19 existing holdings. Its largest new stake was Rigel Pharmaceuticals: 262,500 shares worth $7.43M.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, down from 90% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Vitamin Shoppe Inc., an estimated $1.06M trimmed.

  • Tamarack Advisers's largest Q2 2018 buy was Rigel Pharmaceuticals: 262,500 shares worth $7.43M.
  • Tamarack Advisers added most to OptiNose in Q2 2018, an estimated $12.2M increase.
  • Tamarack Advisers's biggest Q2 2018 reduction was Vitamin Shoppe Inc., cutting an estimated $1.06M.
  • Tamarack Advisers fully exited QuidelOrtho in Q2 2018, selling an estimated $8.55M.
  • Tamarack Advisers's ten largest holdings make up 68% of its $299M portfolio in Q2 2018.
  • Tamarack Advisers opened 5 new positions and closed 4 in Q2 2018.
  • Tamarack Advisers's portfolio value rose 42% quarter-over-quarter to $299M.

Based on Tamarack Advisers's 13F filing for Q2 2018, filed 14 Aug 2018.